News
Panaxia And Neuraxpharm Advance Partnership To Bring Medical Cannabis To France
November 23, 2020 | BENZINGA Israel medical cannabis producer Panaxia Labs Israel (TASE:PNAX) and European pharmaceutical company Neuraxpharm are planning to reach the French market. The two companies have agreed to a production,
Israel’s first commercial medical cannabis export lands in Australia
November 18, 2020 |Jpost Panaxia, in cooperation with Seach Medical Group, two of Israel’s largest manufacturers of medical cannabis products, announced that the country’s first commercial export
Panaxia is the first Israeli company to receive a marketing permit for medical cannabis products in Germany
November 9, 2020 | MarketWatch The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd.(Panaxia Israel) (TASE: PNAX), Israel’s largest medical cannabis manufacturer and Neuraxpharm, its partner, Europe’s largest
Panaxia continues to grow: Panaxia Global Reports that Panaxia Israel ended the 3rd quarter of 2020 with record revenues of at least 16.3 million
October 12, 2020| Yahoo Finance Completes 12 consecutive quarters of revenue increase Projects to complete the first nine months with revenues of at least 43.2 million,